ProShare Advisors LLC Acquires 1,995 Shares of Humana Inc. (NYSE:HUM)

ProShare Advisors LLC raised its holdings in Humana Inc. (NYSE:HUM - Free Report) by 12.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 18,230 shares of the insurance provider's stock after purchasing an additional 1,995 shares during the quarter. ProShare Advisors LLC's holdings in Humana were worth $4,625,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. FPC Investment Advisory Inc. acquired a new position in shares of Humana during the fourth quarter worth approximately $27,000. Centricity Wealth Management LLC bought a new stake in shares of Humana during the fourth quarter valued at approximately $30,000. LFA Lugano Financial Advisors SA grew its stake in shares of Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares during the last quarter. OFI Invest Asset Management bought a new stake in shares of Humana during the fourth quarter valued at approximately $33,000. Finally, Transce3nd LLC bought a new stake in shares of Humana during the fourth quarter valued at approximately $38,000. Institutional investors own 92.38% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Royal Bank of Canada reaffirmed an "outperform" rating and set a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. Morgan Stanley cut their price target on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 12th. Robert W. Baird lifted their price target on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Guggenheim assumed coverage on shares of Humana in a research report on Wednesday, April 9th. They set a "buy" rating and a $326.00 price target for the company. Finally, JPMorgan Chase & Co. reduced their price target on Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research report on Tuesday, February 18th. Seventeen equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $286.81.

Humana Price Performance

Shares of HUM opened at $247.16 on Tuesday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a 50 day simple moving average of $262.90 and a 200 day simple moving average of $269.48. Humana Inc. has a 52-week low of $212.45 and a 52-week high of $406.46. The firm has a market capitalization of $29.83 billion, a PE ratio of 24.84, a P/E/G ratio of 2.05 and a beta of 0.49.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, beating the consensus estimate of $10.07 by $1.51. The business had revenue of $32.11 billion for the quarter, compared to analysts' expectations of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The firm's revenue was up 8.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $7.23 EPS. Sell-side analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio is presently 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.